Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
fda
2
×
institute for clinical and economic review
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
akcea therapeutics
alder biopharmaceuticals
alnylam pharmaceuticals
amgen
biotech
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
clinical trials
david rind
detroit blog main
detroit top stories
drugs
eli lilly
episodic migraine
eptinezumab
erenumab
european medicines agency
food and drug administration
fremanezumab
galcanezumab
harvard pilgrim health care
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
migraine research foundation
What
drug
fda
alnylam
amgen
approval
approves
candidates
cells
class
developed
ema
employ
europe
follows
gene
gets
harmful
head
hits
interference
make
medicine
medicines
method
migraine
mute
new
nod
pain
preventive
protein
rna
rnai
starts
uses
way
won
Language
Current search:
fda
×
" institute for clinical and economic review "
×
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines